miRNAs and Stroke: A Systematic Review
Author Information
Author(s): Yanmeng Yang, Guangming Wang, Yanlong Tang
Primary Institution: First Affiliated Hospital of Dali University, Dali, Yunnan, China
Hypothesis
This systematic review aims to assess the correlation between miRNAs and infarct volume in patients with acute ischemic stroke.
Conclusion
This study shows that miRNA can be used as a biomarker for AIS, reflecting the severity of neurological deficits in this patient and providing a basis for clinical judgement of the patient’s prognosis.
Supporting Evidence
- 9 miRNA indicators were positively associated with infarct volume in patients with AIS.
- miR-155, miR-146b, and miR-181c are among the miRNAs that correlate positively with stroke severity.
- miR-146a and miR-151a-3p were found to be negatively correlated with infarct volume.
Takeaway
Researchers found that certain tiny molecules in the blood, called miRNAs, can help doctors understand how bad a stroke is and predict how well a patient will recover.
Methodology
A systematic review of 17 studies was conducted, assessing the correlation between miRNAs and infarct volume in patients with acute ischemic stroke.
Potential Biases
Potential biases include lack of control for confounding factors and missing data imputation.
Limitations
The quality of included studies varied, and some methodological items were poorly reported.
Participant Demographics
Patients included in the studies had varying ages and sex distributions, with a total of 1443 cases analyzed.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website